Sarah Wilmsmeyer
Medical · Chesterfield, MONPI 1205009552
Payments from drug & device makers
Across 813 payments — averaging $26.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$6K
- Johnson & Johnson$4K
- AbbVie$3K
- Amgen$2K
- Pfizer$1K
- Novartis$1K
- plus $5K from 29 others
What the payments were for
- Consulting fees$5,76326%
- Travel & lodging$1,5427%
- Food & beverage$14,31165%
- Education$3312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 14 | $6,251 |
| Johnson & Johnson(2 entities) | 122 | $3,979 |
| AbbVie | 145 | $2,504 |
| Amgen(2 entities) | 132 | $2,062 |
| Pfizer | 84 | $1,165 |
| Novartis | 71 | $1,111 |
| UCB, Inc. | 53 | $1,070 |
| AstraZeneca(2 entities) | 49 | $1,042 |
| Lilly USA, LLC | 41 | $704 |
| GSK | 17 | $258 |
| Sobi, Inc | 8 | $211 |
| Radius Health, Inc. | 10 | $201 |
| Organon | 7 | $134 |
| E.r. Squibb & Sons, L.L.C. | 8 | $127 |
| Bayer | 1 | $123 |
| Aurinia Pharma U.S., Inc. | 7 | $121 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $93 |
| Sanofi | 4 | $91 |
| ANI Pharmaceuticals, Inc. | 4 | $80 |
| Boehringer Ingelheim | 5 | $79 |
| Sandoz | 4 | $58 |
| Hospira, Inc. | 2 | $57 |
| Pacira Therapeutics, Inc. | 4 | $55 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| Octapharma USA, Inc. | 2 | $46 |
| Grifols USA, LLC | 2 | $44 |
| Kyowa Kirin, Inc. | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Genentech USA, Inc. | 2 | $31 |
| Fresenius Kabi USA, LLC | 2 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Mylan Institutional Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Celltrion USA Inc. | 1 | $17 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$7,649
- STELARA$5,686
- SIMPONI ARIA$134
- Kerendia$123
How this compares
$21,947 in reported general payments places this provider in the 95th percentile of 198 medical providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 21 | $382,742 |
| Enbrel MiniEtanercept | 20 | $179,654 |
| RinvoqUpadacitinib | 17 | $107,315 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $106,837 |
| KevzaraSarilumab | 17 | $73,870 |
| MethotrexateMethotrexate Sodium | 348 | $10,050 |
| Hydroxychloroquine Sulfate | 327 | $9,692 |
| RasuvoMethotrexate/Pf | 14 | $9,491 |
| Leflunomide | 150 | $8,618 |
| Azathioprine | 43 | $3,522 |
| Mycophenolate Mofetil | 35 | $3,055 |
| Sulfasalazine | 80 | $2,919 |
| Sulfasalazine DrSulfasalazine | 68 | $2,855 |
| Gabapentin | 85 | $1,986 |
| Prednisone | 211 | $1,570 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $2,504 | $107,31517 claims |
| SanofiKevzara | $91 | $73,87017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 198 medical providers in Missouri.
Other medical in Chesterfield
- Eileen WeingartChesterfield$2K
- Melanie ChisamSpringfield$92K
- Emily JensenBowling Green$51K
- Amy MosmanSaint Louis$21K
- Dustin BartlettSpringfield$21K
- Alexa Fider-WhyteSaint Louis$18K
- Megan Isaacson-SchmidSaint Louis$16K
- Erin YoffieSaint Louis$16K
- Corey WhitesidesColumbia$15K
- David WinchellSaint Peters$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.